Immunosuppression With Low-Dose Daclizumab in Liver Transplant Recipients With Impaired Kidney Function: A Single-Center Experience

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 3107-3109

  Post, M ^a   Raszeja Wyszomirska, J ^a,b   Jarosz, K ^a   Lubikowski, J ^a   Wasilewicz, M ^a   Mydlowska M ^a   Milkiewicz, P ^a,b   Wojcicki M ^a  

^a M Curie Hospital   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; CREATININE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; LENGTH OF STAY; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; RETROSPECTIVE STUDIES;

EID: 70350518969     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.07.096     Document Type: Article

References (7)

1. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931
2. Cohen A.J., Stegall M.D., Rosen C.B., et al. Chronic renal dysfunction late after liver transplantation. Liver Transpl 8 (2002) 916
3. Wilkinson A., and Pham P.T. Kidney dysfunction in the recipients of liver transplants. Liver Transpl 11 suppl 2 (2005) S47
4. Heffron T.G., Smallwood G.A., De Vera M.E., et al. Daclizumab induction in liver transplant recipients. Transplant Proc 33 (2001) 1527
5. Emre S., Gondolesi G., Polat K., et al. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 7 (2001) 220
6. Sellers M.T., McGuire B.M., Haustein S.V., et al. Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysis. Transplantation 78 (2004) 1212
7. Neuberger J.M., Mamelok R.D., Neuhaus P., et al. Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant 9 (2009) 327